Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
3 359,20 INR
+1,82%
(+60,20) 1D
15-окт., 13:29:12 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
3 330,00 INR
High
3 387,70 INR
Low
3 313,70 INR
Mkt. cap
419,76 млд
Avg. vol.
92,18 миң
Volume
61,04 миң
Dividend
1,58%
Quarterly dividend
13,25 INR
Ex-dividend date
2026-ж., 5-авг.
P/E ratio
36,98
52-wk high
3 796,00 INR
52-wk low
2 382,00 INR
EPS
90,83 INR
Shares outstanding
88,45 млн
No. of employees
10 миң
Open
3 330,00 INR
High
3 387,70 INR
Low
3 313,70 INR
Mkt. cap
419,76 млд
Avg. vol.
92,18 миң
Volume
61,04 миң
Dividend
1,58%
Quarterly dividend
13,25 INR
Ex-dividend date
2026-ж., 5-авг.
P/E ratio
36,98
52-wk high
3 796,00 INR
52-wk low
2 382,00 INR
EPS
90,83 INR
Shares outstanding
88,45 млн
No. of employees
10 миң
News stories
From web sources and news partners
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10,4 миң
Founded1973
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 30-июл.
Fiscal period
Q1 2027
26,72 INR / 22,90 INR
+16,68%beat
Revenue / Est. (INR)
16,26 млд / 15,30 млд
+6,26%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
13,54 млд
13,75 млд
14,22 млд
16,26 млд
Cost of goods sold
3,17 млд
2,86 млд
3,85 млд
3,28 млд
Cost of revenue
3,17 млд
2,86 млд
3,85 млд
3,28 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,17 млд
3,31 млд
3,50 млд
3,81 млд
Operating expense
7,11 млд
7,50 млд
7,05 млд
8,88 млд
Total operating expenses
10,28 млд
10,36 млд
10,90 млд
12,16 млд
Operating income
3,26 млд
3,39 млд
3,32 млд
4,10 млд
Other non operating income
197,10 млн
164,20 млн
-447,90 млн
204,30 млн
EBT including unusual items
3,41 млд
3,59 млд
3,47 млд
4,47 млд
EBT excluding unusual items
3,41 млд
3,59 млд
4,42 млд
4,47 млд
Income tax expense
806,20 млн
848,30 млн
804,10 млн
1,13 млд
Effective tax rate
23,66%
23,66%
23,17%
25,20%
Other operating expenses
3,51 млд
3,76 млд
3,09 млд
4,63 млд
Net income
2,60 млд
2,74 млд
2,67 млд
3,34 млд
Net profit margin
19,22%
19,91%
18,76%
20,56%
Earnings per share
20,82
21,91
21,34
26,72
Interest and investment income
-
-
516,00 млн
-
Interest expense
-33,90 млн
-51,00 млн
-23,60 млн
-31,80 млн
Net interest expenses
-33,90 млн
-51,00 млн
492,40 млн
-31,80 млн
Depreciation and amortization charges
429,70 млн
435,10 млн
453,70 млн
445,00 млн
EBITDA
3,68 млд
3,70 млд
3,70 млд
4,49 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору